de Northern Trust iShares Biotechnology ETF IBB Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 3.85 M | Comprar |
20,236
+261
| +1% | +USD 44.9 k | ﹤0.01% | 2767 |
|
|
2026
Q1 | USD 3.37 M | Vender |
19,975
-344
| -2% | -USD 58.8 k | ﹤0.01% | 2674 |
|
|
2025
Q4 | USD 3.43 M | Comprar |
20,319
+1,897
| +10% | +USD 308 k | ﹤0.01% | 2692 |
|
|
2025
Q3 | USD 2.66 M | Comprar |
18,422
+269
| +1% | +USD 36.7 k | ﹤0.01% | 2874 |
|
|
2025
Q2 | USD 2.3 M | Vender |
18,153
-4,091
| -18% | -USD 502 k | ﹤0.01% | 2909 |
|
|
2025
Q1 | USD 2.85 M | Vender |
22,244
-3,135
| -12% | -USD 425 k | ﹤0.01% | 2735 |
|
|
2024
Q4 | USD 3.36 M | Comprar |
25,379
+967
| +4% | +USD 136 k | ﹤0.01% | 2745 |
|
|
2024
Q3 | USD 3.55 M | Vender |
24,412
-473
| -2% | -USD 68.4 k | ﹤0.01% | 2680 |
|
|
2024
Q2 | USD 3.42 M | Vender |
24,885
-2,465
| -9% | -USD 329 k | ﹤0.01% | 2610 |
|
|
2024
Q1 | USD 3.75 M | Vender |
27,350
-1,146
| -4% | -USD 157 k | ﹤0.01% | 2644 |
|
|
2023
Q4 | USD 3.87 M | Comprar |
28,496
+1,210
| +4% | +USD 148 k | ﹤0.01% | 2654 |
|
|
2023
Q3 | USD 3.34 M | Vender |
27,286
-1,526
| -5% | -USD 194 k | ﹤0.01% | 2669 |
|
|
2023
Q2 | USD 3.66 M | Vender |
28,812
-1,202
| -4% | -USD 156 k | ﹤0.01% | 2674 |
|
|
2023
Q1 | USD 3.88 M | Comprar |
30,014
+212
| +0.7% | +USD 27.8 k | ﹤0.01% | 2608 |
|
|
2022
Q4 | USD 3.91 M | Vender |
29,802
-3,498
| -11% | -USD 452 k | ﹤0.01% | 2631 |
|
|
2022
Q3 | USD 3.9 M | Vender |
33,300
-1,910
| -5% | -USD 237 k | ﹤0.01% | 2640 |
|
|
2022
Q2 | USD 4.14 M | Vender |
35,210
-3,426
| -9% | -USD 407 k | ﹤0.01% | 2625 |
|
|
2022
Q1 | USD 5.04 M | Vender |
38,636
-4,992
| -11% | -USD 650 k | ﹤0.01% | 2583 |
|
|
2021
Q4 | USD 6.66 M | Comprar |
43,628
+6,385
| +17% | +USD 989 k | ﹤0.01% | 2521 |
|
|
2021
Q3 | USD 6.02 M | Vender |
37,243
-3,558
| -9% | -USD 599 k | ﹤0.01% | 2615 |
|
|
2021
Q2 | USD 6.68 M | Vender |
40,801
-1,881
| -4% | -USD 290 k | ﹤0.01% | 2650 |
|
|
2021
Q1 | USD 6.43 M | Vender |
42,682
-3,795
| -8% | -USD 603 k | ﹤0.01% | 2586 |
|
|
2020
Q4 | USD 7.04 M | Vender |
46,477
-3,686
| -7% | -USD 527 k | ﹤0.01% | 2474 |
|
|
2020
Q3 | USD 6.79 M | Comprar |
50,163
+862
| +2% | +USD 117 k | ﹤0.01% | 2343 |
|
|
2020
Q2 | USD 6.74 M | Vender |
49,301
-4,464
| -8% | -USD 569 k | ﹤0.01% | 2343 |
|
|
2020
Q1 | USD 5.79 M | Vender |
53,765
-5,278
| -9% | -USD 608 k | ﹤0.01% | 2208 |
|
|
2019
Q4 | USD 7.12 M | Vender |
59,043
-2,958
| -5% | -USD 330 k | ﹤0.01% | 2384 |
|
|
2019
Q3 | USD 6.17 M | Vender |
62,001
-2,165
| -3% | -USD 227 k | ﹤0.01% | 2429 |
|
|
2019
Q2 | USD 7 M | Vender |
64,166
-7,706
| -11% | -USD 820 k | ﹤0.01% | 2365 |
|
|
2019
Q1 | USD 8.04 M | Vender |
71,872
-3,982
| -5% | -USD 437 k | ﹤0.01% | 2296 |
|
|
2018
Q4 | USD 7.31 M | Vender |
75,854
-6,382
| -8% | -USD 677 k | ﹤0.01% | 2269 |
|
|
2018
Q3 | USD 10 M | Vender |
82,236
-7,552
| -8% | -USD 889 k | ﹤0.01% | 2253 |
|
|
2018
Q2 | USD 9.9 M | Comprar |
89,788
+1,098
| +1% | +USD 117 k | ﹤0.01% | 2277 |
|
|
2018
Q1 | USD 9.47 M | Vender |
88,690
-11,208
| -11% | -USD 1.24 M | ﹤0.01% | 2199 |
|
|
2017
Q4 | USD 10.7 M | Vender |
99,898
-18,734
| -16% | -USD 2 M | ﹤0.01% | 2140 |
|
|
2017
Q3 | USD 13.2 M | Comprar |
118,632
+1,170
| +1% | +USD 125 k | ﹤0.01% | 2015 |
|
|
2017
Q2 | USD 12.1 M | Vender |
117,462
-3,063
| -3% | -USD 302 k | ﹤0.01% | 2039 |
|
|
2017
Q1 | USD 11.8 M | Vender |
120,525
-1,329
| -1% | -USD 127 k | ﹤0.01% | 2011 |
|
|
2016
Q4 | USD 10.8 M | Vender |
121,854
-15,864
| -12% | -USD 1.44 M | ﹤0.01% | 2068 |
|
|
2016
Q3 | USD 13.3 M | Comprar |
137,718
+4,434
| +3% | +USD 422 k | ﹤0.01% | 1877 |
|
|
2016
Q2 | USD 11.4 M | Vender |
133,284
-7,761
| -6% | -USD 696 k | ﹤0.01% | 1936 |
|
|
2016
Q1 | USD 12.3 M | Vender |
141,045
-10,503
| -7% | -USD 939 k | ﹤0.01% | 1822 |
|
|
2015
Q4 | USD 17.1 M | Vender |
151,548
-846
| -0.6% | -USD 91.8 k | 0.01% | 1615 |
|
|
2015
Q3 | USD 15.4 M | Vender |
152,394
-9,411
| -6% | -USD 1.13 M | 0.01% | 1683 |
|
|
2015
Q2 | USD 19.9 M | Comprar |
161,805
+1,110
| +0.7% | +USD 133 k | 0.01% | 1590 |
|
|
2015
Q1 | USD 18.4 M | Comprar |
160,695
+45
| +0% | +USD 4.96 k | 0.01% | 1645 |
|
|
2014
Q4 | USD 16.2 M | Comprar |
160,650
+6,411
| +4% | +USD 623 k | ﹤0.01% | 1698 |
|
|
2014
Q3 | USD 14.1 M | Vender |
154,239
-5,646
| -4% | -USD 495 k | ﹤0.01% | 1786 |
|
|
2014
Q2 | USD 13.7 M | Vender |
159,885
-4,560
| -3% | -USD 359 k | ﹤0.01% | 1812 |
|
|
2014
Q1 | USD 13 M | Comprar |
164,445
+10,950
| +7% | +USD 912 k | ﹤0.01% | 1920 |
|
|
2013
Q4 | USD 11.6 M | Vender |
153,495
-1,449
| -0.9% | -USD 103 k | ﹤0.01% | 1970 |
|
|
2013
Q3 | USD 10.8 M | Comprar |
154,944
+5,991
| +4% | +USD 392 k | ﹤0.01% | 1975 |
|
|
2013
Q2 | USD 8.63 M | Comprar |
+148,953
| Nuevas | +USD 8.61 M | ﹤0.01% | 2024 |
|
Otros fondos que tienen IBB en su cartera
Posición de Northern Trust en IBB: resumen de T2 2026
Northern Trust aumentó su participación en iShares Biotechnology ETF (IBB) en 1.3% durante T2 2026, al comprar aproximadamente USD 44.9 k y elevar la posición a 20,236 acciones con un valor de USD 3.85 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2767.
Northern Trust reportó por primera vez una posición en IBB en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 19.9 M en T2 2015. Al cierre de T2 2026, 960 fondos que sigue Wall St. Rank mantienen una posición en IBB.
- Al cierre de T2 2026, Northern Trust tenía 20,236 acciones de iShares Biotechnology ETF con un valor de USD 3.85 M.
- Northern Trust compró 261 acciones de iShares Biotechnology ETF en T2 2026, por un monto estimado de USD 44.9 k.
- iShares Biotechnology ETF representó ﹤0.01% de la cartera de Northern Trust en T2 2026 y fue su posición número 2767.
- Northern Trust reportó por primera vez una posición en iShares Biotechnology ETF en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Northern Trust en iShares Biotechnology ETF alcanzó su máximo de USD 19.9 M en T2 2015.
- Al cierre de T2 2026, 960 fondos que sigue Wall St. Rank tenían iShares Biotechnology ETF en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.